See more : Microcosm Technology Co., Ltd. (3354.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Naturally Splendid Enterprises Ltd. (NSPDF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Naturally Splendid Enterprises Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Aristocrat Leisure Limited (ALL.AX) Income Statement Analysis – Financial Results
- ETS Group Limited (8031.HK) Income Statement Analysis – Financial Results
- Changyou Alliance Group Limited (1039.HK) Income Statement Analysis – Financial Results
- Canadian Life Companies Split Corp. (CLSPF) Income Statement Analysis – Financial Results
- Ventana Biotech, Inc. (VNTA) Income Statement Analysis – Financial Results
Naturally Splendid Enterprises Ltd. (NSPDF)
About Naturally Splendid Enterprises Ltd.
Naturally Splendid Enterprises Ltd. develops, produces, commercializes, and sells plant-derived, bio-active ingredients, nutrient dense foods, and related products in Canada. The company offers nutrition for athletes under the Natera Sport brand; mushroom fortified bars under the Woods Wild; protein bars under the Elevate Me brand; Hemp Foods under the CHII brand; products for dogs under the PawsitiveFX brand; and health and wellness products under the Natera FX brand, as well as products for the equestrian market under the Timer's Nutrition brand. It also develops, manufactures, and distributes healthy lifestyle and meal replacement products. The company sells food and ingredients to commercial processors and consumers through grocery stores, health and nutrition stores, and online. It exports its products to the United States, Australia, and South Korea. Naturally Splendid Enterprises Ltd. is headquartered in Pitt Meadows, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 763.80K | 1.58M | 3.04M | 2.07M | 1.77M | 7.35M | 301.71K | 234.76K | 132.58K | 99.66K | 0.00 |
Cost of Revenue | 0.00 | 681.62K | 1.46M | 2.11M | 1.55M | 1.51M | 6.11M | 244.55K | 193.09K | 107.91K | 69.79K | 0.00 |
Gross Profit | 0.00 | 82.18K | 116.13K | 922.80K | 524.12K | 263.92K | 1.23M | 57.16K | 41.67K | 24.67K | 29.87K | 0.00 |
Gross Profit Ratio | 0.00% | 10.76% | 7.37% | 30.38% | 25.27% | 14.88% | 16.80% | 18.94% | 17.75% | 18.61% | 29.97% | 0.00% |
Research & Development | 0.00 | 12.06K | 0.00 | 14.80K | 11.66K | 167.32K | 36.01K | 154.74K | 7.94K | 24.30K | 18.75K | 0.00 |
General & Administrative | 0.00 | 1.66M | 2.15M | 3.05M | 4.86M | 4.20M | 2.84M | 3.14M | 1.25M | 906.47K | 126.53K | 110.52K |
Selling & Marketing | 0.00 | 591.97K | 1.47M | 2.26M | 1.06M | 119.19K | 538.82K | 901.69K | 521.94K | 496.06K | 280.00 | 392.00 |
SG&A | 0.00 | 2.25M | 3.62M | 5.31M | 5.93M | 4.32M | 3.38M | 4.04M | 1.77M | 1.40M | 126.81K | 110.91K |
Other Expenses | 0.00 | -141.12K | -220.47K | -130.00K | -565.00K | 161.73K | 51.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 2.83M | 4.26M | 6.24M | 6.39M | 4.83M | 3.65M | 4.33M | 1.83M | 1.44M | 126.81K | 110.91K |
Cost & Expenses | 0.00 | 3.51M | 5.72M | 8.35M | 7.94M | 6.34M | 9.77M | 4.57M | 2.03M | 1.55M | 126.81K | 110.91K |
Interest Income | 0.00 | 300.00 | 368.00 | 5.86K | 11.20K | 0.00 | 907.00 | 1.73K | 2.84K | 5.72K | 633.00 | 685.00 |
Interest Expense | 0.00 | 305.51K | 290.21K | 301.85K | 35.22K | 100.32K | 269.26K | 50.10K | 4.90K | 3.35K | 159.00 | 290.00 |
Depreciation & Amortization | 228.49K | 566.30K | 642.80K | 910.89K | 452.74K | 300.84K | 237.62K | 134.66K | 30.37K | 17.41K | 6.64K | 290.00 |
EBITDA | 0.00 | -2.27M | -3.73M | -4.53M | -5.40M | -4.02M | -2.27M | -4.13M | -1.76M | -1.40M | -126.18K | -110.91K |
EBITDA Ratio | 0.00% | -285.81% | -222.04% | -149.11% | -260.51% | -238.19% | -29.67% | -1,370.10% | -749.47% | -1,053.29% | -126.61% | 0.00% |
Operating Income | 0.00 | -2.75M | -4.14M | -5.44M | -5.86M | -5.02M | -2.85M | -4.32M | -1.80M | -1.42M | -126.97K | -111.20K |
Operating Income Ratio | 0.00% | -359.95% | -262.82% | -179.09% | -282.34% | -282.84% | -38.73% | -1,431.92% | -765.70% | -1,073.27% | -127.40% | 0.00% |
Total Other Income/Expenses | 0.00 | -392.36K | -516.22K | -1.71M | -871.13K | -253.31K | -504.37K | -2.92M | 1.81K | -1.32M | 633.00 | 685.00 |
Income Before Tax | 0.00 | -3.14M | -4.66M | -7.03M | -6.73M | -4.86M | -2.78M | -6.98M | -1.80M | -2.75M | -126.34K | -110.51K |
Income Before Tax Ratio | 0.00% | -411.36% | -295.59% | -231.44% | -324.35% | -274.08% | -37.78% | -2,313.94% | -764.93% | -2,070.53% | -126.77% | 0.00% |
Income Tax Expense | 0.00 | 305.51K | 290.21K | 171.85K | -43.65K | -43.81K | 116.30K | -58.97K | 4.90K | 3.35K | 189.41K | -685.00 |
Net Income | 0.00 | -3.14M | -4.66M | -7.03M | -1.60M | -4.58M | -2.62M | -6.87M | -1.80M | -2.75M | -126.34K | -110.51K |
Net Income Ratio | 0.00% | -411.36% | -295.59% | -231.44% | -76.97% | -258.07% | -35.70% | -2,277.79% | -764.93% | -2,070.53% | -126.77% | 0.00% |
EPS | 0.00 | -0.22 | -0.41 | -0.88 | -0.24 | -0.89 | -0.65 | -2.00 | -0.89 | -1.67 | -0.95 | -1.30 |
EPS Diluted | 0.00 | -0.22 | -0.41 | -0.88 | -0.24 | -0.89 | -0.65 | -2.00 | -0.89 | -1.67 | -0.95 | -1.30 |
Weighted Avg Shares Out | 0.00 | 14.56M | 11.42M | 7.96M | 6.62M | 5.17M | 4.03M | 3.44M | 2.01M | 1.64M | 133.33K | 84.75K |
Weighted Avg Shares Out (Dil) | 0.00 | 14.56M | 11.42M | 7.96M | 6.62M | 5.17M | 4.03M | 3.44M | 2.01M | 1.64M | 133.33K | 84.75K |
Naturally Splendid Reports Year End Results for 2020 and Provides 2021 Outlook
Naturally Splendid appoints CANEX Foods as master distributor for NATERA Plant Based Foods in Canada
Wall Street brushes off initial worries over potential capital gains tax hike
Naturally Splendid Receives Additional Container of NATERA Plant Based Foods from Australia
Naturally Splendid Enterprises appoints marketing executive, Drago Adam to its Advisory Board
Naturally Splendid Appoints Marketing Executive to Advisory Board
Naturally Splendid Enterprises moving to selecting subjects for Phase 2 clinical trial to evaluate Cavaltinib as coronavirus treatment
Naturally Splendid Enterprises ships fifth container of hemp seed to South Korea
Naturally Splendid appoints digital marketing veteran Kris Tarr as VP of e-commerce
Naturally Splendid Enterprises brings in further C$612,865 cash from warrant exercise
Source: https://incomestatements.info
Category: Stock Reports